Intrinsiqq
Outset Medical Inc. logo

Outset Medical Inc. Financials

OM

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 9 available years
Income Statement
TTM
DEC 2025
4392:1 split
DEC 2024
DEC 2023
DEC 2022
DEC 2021
~2.8:1 split
Revenues
Revenue$122$119$114$130$115$103
Cost of Revenue$71$73$75$101$98$95
Gross Profit$51$47$39$29$18$8
Operating Expenses
Selling & Marketing$50$54$70$96$89$65
General & Administrative$42$38$43$45$41$36
Research & Development$22$21$38$57$49$37
Provision for Doubtful Accounts$6$4$2––$0
Total Operating Expenses$114$113$152$199$179$138
Operating Income-$62-$67-$113-$170-$161-$131
Non-Operating
Net Interest Expense-$14-$14-$24-$13-$4-$2
Other Non-Operating Income (Expense)$6-$0$10$10$2$0
EBT (Earnings Before Tax)-$70-$81-$127-$172-$163-$132
Income Tax Expense$1$1$0$1$0$0
Net Income
Net Income-$71-$82-$128-$173-$163-$132
Per Share Data
Revenue Per Share$6,476.98$7.85$32,825.84$39,437.77$35.93$33.76
EPS (Basic)-$2.45-$5.37-$36.96-$52.28-$50.70-$43.35
EPS (Diluted)-$2.45-$5.37-$36.96-$52.28-$50.70-$43.35
Weighted Avg Shares (Basic)18,83115,21151,95149,58848,16145,589
Weighted Avg Shares (Diluted)18,83115,21151,95149,58848,16145,589
Shares Outstanding18,83115.2M3,463.43,305.8673.2M3.0M

Outset Medical (OM) financials: revenue, profit and margins

Outset Medical (OM) generated about $118 million in revenue and -$74 million in net income (a -63.1% net margin) over the trailing twelve months, growing at roughly 19.1% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Outset Medical's (OM) revenue?+

Outset Medical generated about $118 million in revenue over the trailing twelve months. Revenue has grown at roughly 19.1% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Outset Medical profitable?+

Outset Medical reported about -$74 million in net loss over the trailing twelve months, a net margin of roughly -63.1%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Outset Medical's profit margins?+

Outset Medical runs a gross margin of about 41.8%, an operating margin of about -56.1%, a net margin of about -63.1%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Outset Medical growing?+

Outset Medical's revenue has compounded at roughly 19.1% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside OM's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 4 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 8 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with OM

CompareIntrinsic value
ZYXIQZynex Inc
No recent price20
BLFSBiolife Solutions Inc.
No recent price61
FONRFonar Corp
No recent price53
CBLLCeribell, Inc.
$27.39-3.11%25
VASOVaso Corporation
$0.29+0.00%37
ELMDElectromed Inc.
$28.01+4.83%75
EDAPEdap Tms SA
$4.34+5.60%15
IRIXIridex Corporation
$0.72+2.86%25

Held by ETFs

OM is in 2 US ETFs. The largest of them, with OM's weight in each:

Spot a number that looks wrong? Check it in OM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OM

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.